A study showed meningitis B vaccines like GlaxoSmithKline’s Bexsero can provide some protection against gonorrhea, and now the drugmaker is analyzing whether to move forward with testing in the disease area.
A study showed meningitis B vaccines like GlaxoSmithKline’s Bexsero can provide some protection against gonorrhea, and now the drugmaker is analyzing whether to move forward with testing in the disease area.
With a new captain at the helm, GlaxoSmithKline maintained its vaccines momentum in the first quarter with 16% growth for the unit, thanks to standout sales from meningitis shots picked up in its Novartis deal.